Researchers studied a new monthly pill that combines two bone-strengthening medicines for women after menopause whose bones are becoming weaker. The pill contains ibandronic acid (which slows bone loss) and vitamin D (which helps bones absorb calcium). Over 200 women in Portugal took this pill for six months. Almost all of them took their medicine as prescribed, most kept taking it for the full six months, and they reported being very satisfied with the treatment. The pill was generally safe and well-tolerated, with only minor side effects like joint pain or upset stomach in a small number of women.
The Quick Take
- What they studied: How well women stick with taking a monthly bone-strengthening pill that combines two medicines, whether they’re satisfied with it, and whether it’s safe.
- Who participated: 211 postmenopausal women (women past their reproductive years) from Portugal who had weak bones and low vitamin D levels. Most had never taken this specific combination pill before.
- Key finding: Nearly 99% of women took their pill as directed, about 86% kept taking it for the full six months, and women reported high satisfaction scores (around 82 out of 100). Only about 6% experienced mild side effects.
- What it means for you: If you’re a postmenopausal woman with weak bones, this monthly pill might be easier to remember and stick with compared to more frequent doses, and most women tolerated it well. However, this study only lasted six months, so long-term benefits and safety need more research.
The Research Details
This was a real-world study conducted in community pharmacies across Portugal, meaning researchers watched how women actually used the medicine in their daily lives rather than in a controlled laboratory setting. The study followed 230 women initially, with 211 completing the full six-month period. Researchers collected information through patient diaries (where women recorded if they took their pill), pharmacy records (tracking actual purchases), and questionnaires asking about satisfaction and side effects. Two main visits occurred: one at the start and one after six months of treatment.
The researchers used a specific satisfaction questionnaire called OPSAT-Q, which is designed specifically to measure how happy patients are with osteoporosis treatments. This questionnaire asks about convenience, effectiveness, and overall satisfaction with the medicine. The study tracked both women who were new to this particular pill combination and women who had taken it before to see if experience made a difference.
This type of real-world study is important because it shows how people actually use medicines in their homes, not just in perfect laboratory conditions. Understanding whether women actually take their medicine as prescribed (compliance) and keep taking it over time (persistence) is crucial because a medicine only works if people actually use it. High satisfaction scores matter because if people like their treatment, they’re more likely to keep taking it, which means better bone health and fewer fractures.
Strengths of this study include a reasonable sample size (211 women completed it), a six-month follow-up period, and use of multiple sources of information (diaries, pharmacy records, and questionnaires) to track compliance. The study was conducted across multiple pharmacy locations, which makes the results more representative of real-world use. Limitations include the relatively short six-month timeframe (bone health benefits typically take longer to fully appear), the lack of a comparison group taking a different treatment, and the fact that it only included women in Portugal, so results may not apply to all populations.
What the Results Show
The study found excellent adherence to the monthly pill regimen. Of the 180 women with complete compliance data, 98.7% took their medicine as prescribed during the six-month period. This is notably high compared to many other bone-strengthening medications, which suggests the once-monthly dosing schedule is convenient and easy for women to remember.
Persistence—meaning women continued taking the pill throughout the study—was also strong at 85.8%. This means that out of 211 women who completed the study, about 181 kept taking their medicine for the full six months without stopping. In medical terms, this is considered very good persistence.
Patient satisfaction was high, with satisfaction scores averaging around 82 out of 100 on two different satisfaction measures. Women reported being pleased with the convenience of taking just one pill per month and felt the treatment was working for them. Importantly, there was no meaningful difference in compliance, persistence, or satisfaction between women taking this pill combination for the first time and women who had taken it before.
The safety profile was favorable overall. The most common side effects were joint pain (arthralgia) and upset stomach (dyspepsia), occurring in about 6.2% of women. These are generally mild and manageable side effects. No serious safety concerns emerged during the six-month study period. The fact that side effects were infrequent and mild likely contributed to the high satisfaction scores and good persistence rates.
Previous research on bone-strengthening medications shows that women often struggle to take them regularly because they require frequent dosing (sometimes weekly or daily) or complicated instructions. This monthly pill format appears to address a major barrier to treatment success. The high compliance and persistence rates in this study are comparable to or better than what’s been reported for other osteoporosis treatments, suggesting the simplified dosing schedule is a real advantage.
The study lasted only six months, which is relatively short for evaluating bone health treatments that typically show maximum benefits over one to two years. Without a comparison group taking a different treatment or a placebo, we can’t definitively say this pill is better than alternatives—only that it’s well-tolerated and easy to use. The study included only women in Portugal, so results may differ in other countries with different healthcare systems or populations. Additionally, the study didn’t measure actual bone density changes or fracture rates, only whether women took their medicine and were satisfied with it.
The Bottom Line
For postmenopausal women with weak bones and low vitamin D levels, this monthly pill combination appears to be a good option with high confidence. The evidence strongly supports that it’s easy to remember to take, well-tolerated, and satisfying to use. However, this should be discussed with your doctor to ensure it’s appropriate for your specific situation. The recommendation is moderate-to-high confidence because the study was well-designed but relatively short-term.
This research is most relevant to postmenopausal women diagnosed with osteoporosis (weak bones) who also have vitamin D insufficiency. Women who struggle to remember to take daily or weekly medications may particularly benefit from a monthly option. This may be less relevant for women with normal bone density, men, or premenopausal women. Anyone with kidney disease, certain allergies, or specific medical conditions should discuss this with their doctor before starting.
In this study, women reported satisfaction and good tolerance within six months. However, actual improvements in bone density and fracture risk reduction typically take 12-24 months of consistent treatment. You should expect to take this medicine for at least one year before seeing meaningful improvements in bone strength, and ideally for several years for maximum benefit.
Want to Apply This Research?
- Set a monthly reminder on the same date each month (for example, the first of every month) to take your pill. Track in the app whether you took it on schedule, aiming for 100% compliance. You could also log any side effects you experience, such as joint pain or stomach discomfort, to discuss with your doctor.
- Use the app to set a recurring monthly alarm notification on the same day each month. Create a simple checklist where you mark off each month after taking your pill. This visual record helps you stay accountable and makes it easy to see your compliance pattern over time.
- Over the long term (6-12 months), use the app to track your overall compliance percentage and any patterns in side effects. Share this data with your doctor at follow-up visits. If you notice you’re missing doses, the app can help you identify barriers (like forgetting the date) and adjust your strategy (like linking it to another monthly event you always remember).
This research describes a specific bone-strengthening medication combination and should not be considered personal medical advice. If you are a postmenopausal woman with weak bones or low vitamin D, consult with your doctor or healthcare provider before starting, stopping, or changing any osteoporosis treatment. This study lasted only six months; long-term safety and effectiveness require ongoing medical supervision. Women with kidney disease, certain allergies, or other medical conditions may not be appropriate candidates for this treatment. Always inform your healthcare provider about all medications and supplements you’re taking, as some may interact with this treatment.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.